Myers M P, Stolarov J P, Eng C, Li J, Wang S I, Wigler M H, Parsons R, Tonks N K
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.
Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9052-7. doi: 10.1073/pnas.94.17.9052.
Protein tyrosine phosphatases (PTPs) have long been thought to play a role in tumor suppression due to their ability to antagonize the growth promoting protein tyrosine kinases. Recently, a candidate tumor suppressor from 10q23, termed P-TEN, was isolated, and sequence homology was demonstrated with members of the PTP family, as well as the cytoskeletal protein tensin. Here we show that recombinant P-TEN dephosphorylated protein and peptide substrates phosphorylated on serine, threonine, and tyrosine residues, indicating that P-TEN is a dual-specificity phosphatase. In addition, P-TEN exhibited a high degree of substrate specificity, showing selectivity for extremely acidic substrates in vitro. Furthermore, we demonstrate that mutations in P-TEN, identified from primary tumors, tumor cells lines, and a patient with Bannayan-Zonana syndrome, resulted in the ablation of phosphatase activity, demonstrating that enzymatic activity of P-TEN is necessary for its ability to function as a tumor suppressor.
由于蛋白酪氨酸磷酸酶(PTPs)具有拮抗促进生长的蛋白酪氨酸激酶的能力,长期以来人们一直认为它们在肿瘤抑制中发挥作用。最近,从10q23分离出一种名为P - TEN的候选肿瘤抑制因子,它与PTP家族成员以及细胞骨架蛋白张力蛋白具有序列同源性。我们在此表明,重组P - TEN能使丝氨酸、苏氨酸和酪氨酸残基磷酸化的蛋白质和肽底物去磷酸化,这表明P - TEN是一种双特异性磷酸酶。此外,P - TEN表现出高度的底物特异性,在体外对极端酸性底物具有选择性。此外,我们证明,从原发性肿瘤、肿瘤细胞系以及一名患有班纳扬 - 佐纳纳综合征的患者中鉴定出的P - TEN突变导致磷酸酶活性丧失,这表明P - TEN的酶活性是其作为肿瘤抑制因子发挥功能所必需的。